Theoretical Study of the interaction of Chlorambucil and Melphalan with carbon nanotube surface as a drug nanocarrier in aqueous solution

Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:
Biological application of carbon nanotubes in drug delivery is our main concern in this investigation. For this purpose, possibility of the interaction of chlorambucil and melphalan with carbon nanotube surface as a carrier was studied in both gas phase and in aqueous media. At first step each species was modeled using quantum mechanical calculations, in the next step, solvation free energies and association free energies of considered structures in water were studied by Monte Carlo simulation and perturbation method. The results of density functional calculations in gas phase showed that both two drugs can interact with carbon nanotube. Monte Carlo simulation results revealed that interaction with carbon nanotube enhanced the solubility of drugs in water which improve the pharmaceutical applications. Calculated association free energies indicated that melphalan produced more stable complex with carbon nanotube than chorambucil in aqueous solution. This tendency could be observed in gas and liquid phase similarly.
Language:
Persian
Published:
Pages:
96 to 103
magiran.com/p2508497  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!